Broegelmann Research Laboratory

The researchers at the Broegelmann Research Laboratory have a common interest in translational research on chronic inflammatory and autoimmune diseases. The research performed spans from molecular and genetic studies, cellular studies and experimental models as well as studies on clinically well-characterized patient samples. The mutual ambition is to understand the molecular mechanisms active in different inflammatory diseases and their subgroups, their underlying risk factors and triggers. This paves the way for better, personalized treatment and ultimately to prevention of disease.

Main content

Current major areas of research:

Translational studies in autoimmunity; autoantibodies and biomarkers
Immunopathogenesis of juvenile idiopathic arthritis
Functional genomics and genetic basis of the autoimmune exocrinopathy (Sjögren’s disease)
Host microbe interactions (P. gingivalis – arthritis, Alzheimer)
Hyperinflammatory primary immunodeficiency syndromes
Role of HMGB1 in inflammation
Novel natural product based COVID-19 therapy
Intestinal mucosal microenvironment in irritable bowel syndrome

Contact us.

Administrative inquiries: Victoria Jensen, E-mail: victoria.jensen@uib.no

General inquiries: Richard Davies, E-mail: E-mail: richard.davies@uib.no

Address: Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, The Laboratory Building 5th floor, Haukeland University Hospital

Research into SS at BRL

Sjogrens research at BRL (English)

forskning pa sjogrens syndrom (norsk)

Groups

Harris group

Helena Erlandsson Harris leads the Harris group. She did her undergraduate training at the University of Uppsala and PhD at the Karolinska Institutet, Sweden. She was appointed professor at Karolinska institutet in 2014. She became head of the Broegelmann Research Laboratory and Professor in...

Duodenum image by Hyperion imaging mass cytometry system

Appel Group

Silke Appel leads the Appel group. She did her PhD at the Max-Delbrück Center for Molecular Medicine, Germany followed by post-doctoral work at the Universitätsklinikum Tübingen, Germany and the University of Bergen. She was awarded the Trond Mohn Starting Grant 2007, She was appointed professor at...

Mydel Group

Piotr Mydel leads the Mydel group. He did his PhD education at the Jagiellonian University in Krakow, Poland and at the University of Boston, MA, USA followed by post-doctoral work at Washington University, University of Gothenburg and University of Bergen. He was appointed Professor I at the...

Yenan Brycesson, Group leader Brycesson group

Bryceson Group

Yenan Bryceson leads the Bryceson group. He did his undergraduate training at the University of Oslo and PhD at the National Institutes of Health, Rockville, MD, USA. He was appointed professor II at the University of Bergen in 2012. He is also a professor at Karolinska Institutet, Stockholm, Sweden.

Wahren-Herlenius Group

Marie Wahren-Herlenius leads the Wahren-Herlenius Group. Marie did part of her PhD training and a postdoctoral period at the Broegelmann Research Laboratory. She was appointed professor II, University of Bergen in 2020. She is also a professor at Karolinska Institutet, Stockholm, Sweden, and...

06.03.2025